Literature DB >> 10952595

Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.

P M Furneri1, M Fresta, G Puglisi, G Tempera.   

Abstract

Different ofloxacin-loaded unilamellar vesicles were prepared by the extrusion technique, and their antimicrobial activities were determined in comparison to those of the free drug by means of MIC determinations with both American Type Culture Collection standards and wild-type bacterial strains (six strains of Enterococcus faecalis, seven strains of Escherichia coli, six strains of Staphylococcus aureus, and six strains of Pseudomonas aeruginosa). The accumulation of ofloxacin and liposome-ofloxacin was measured by determining the amount of the drug inside the bacteria as a function of time. Encapsulated fluoroquinolone yielded MICs which were at least twofold lower than those obtained with the free drug. In particular, liposomes made up of dimyristoylphosphatidylcholine-cholesterol-dipalmitoylphosphatidylser ine and dimyristoylphosphatidylcholine-cholesterol-dihexadecylphosphate (4:3:4 molar ratio) provided the best improvement in antimicrobial activity against the various bacterial strains investigated. The liposome formulation produced higher intracellular fluoroquinolone concentrations than those achieved simultaneously with the free drug in both E. coli and P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952595      PMCID: PMC90085          DOI: 10.1128/AAC.44.9.2458-2464.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

Review 1.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles.

Authors:  L D Mayer; M J Hope; P R Cullis; A S Janoff
Journal:  Biochim Biophys Acta       Date:  1985-07-11

3.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.

Authors:  S Chamberland; A S Bayer; T Schollaardt; S A Wong; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F.

Authors:  W A Woodruff; T R Parr; R E Hancock; L F Hanne; T I Nicas; B H Iglewski
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

6.  Structure-activity relationship of fluoroquinolone in Escherichia coli.

Authors:  S Lee; T Park; Y Lee
Journal:  Arch Pharm Res       Date:  1998-04       Impact factor: 4.946

7.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

8.  Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency.

Authors:  S Benita; P A Poly; F Puisieux; J Delattre
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

9.  Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.

Authors:  H Aoyama; K Sato; T Fujii; K Fujimaki; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

10.  Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.

Authors:  N J Robillard; A L Scarpa
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more
  9 in total

1.  Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin.

Authors:  Khaled Mohamed Hosny
Journal:  AAPS PharmSciTech       Date:  2009-11-10       Impact factor: 3.246

2.  Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Authors:  Hui Xin Ong; Daniela Traini; David Cipolla; Igor Gonda; Mary Bebawy; Helen Agus; Paul M Young
Journal:  Pharm Res       Date:  2012-07-26       Impact factor: 4.200

3.  Rhamnolipid-Based Liposomes as Promising Nano-Carriers for Enhancing the Antibacterial Activity of Peptides Derived from Bacterial Toxin-Antitoxin Systems.

Authors:  Beatriz Cristina Pecoraro Sanches; Camila Aguiar Rocha; Jose Gregorio Martin Bedoya; Vinicius Luiz da Silva; Patrícia Bento da Silva; Ana Marisa Fusco-Almeida; Marlus Chorilli; Jonas Contiero; Edson Crusca; Reinaldo Marchetto
Journal:  Int J Nanomedicine       Date:  2021-02-10

4.  Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles.

Authors:  Shuyu Xie; Luyan Zhu; Zhao Dong; Yan Wang; Xiaofang Wang; WenZhong Zhou
Journal:  Int J Nanomedicine       Date:  2011-03-15

5.  Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis.

Authors:  Chih-Chang Yeh; Yu-Han Su; Yu-Jhe Lin; Pin-Jyun Chen; Chung-Sheng Shi; Cheng-Nan Chen; Hsin-I Chang
Journal:  Drug Des Devel Ther       Date:  2015-04-20       Impact factor: 4.162

6.  Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm.

Authors:  Dong Dong; Nicky Thomas; Benjamin Thierry; Sarah Vreugde; Clive A Prestidge; Peter-John Wormald
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

Review 7.  Advances in nanomedicine for the treatment of ankylosing spondylitis.

Authors:  Yanhai Xi; Tingwang Jiang; Birendra Chaurasiya; Yanyan Zhou; Jiangmin Yu; Jiankun Wen; Yan Shen; Xiaojian Ye; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-10-29

8.  S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model.

Authors:  Xiaobo Fan; Juxiang Fan; Xiyong Wang; Pengpeng Wu; Guoqiu Wu
Journal:  Front Pharmacol       Date:  2015-10-27       Impact factor: 5.810

9.  Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor.

Authors:  Menka Drost; Eleonora Diamanti; Kathrin Fuhrmann; Adriely Goes; Atanaz Shams; Jörg Haupenthal; Marcus Koch; Anna K H Hirsch; Gregor Fuhrmann
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.